Company news

Zhejiang Huakang Pharmaceutical Co., Ltd. Class A (SSE:605077) news

Zhejiang Huakang Pharmaceutical Co., Ltd. Class A news releases on 6ix. Latest, Sep 19, 2026: "Zhejiang Huakang Pharmaceutical Co., Ltd."Announcement…

Zhejiang Huakang Pharmaceutical Co., Ltd. Class A (SSE:605077) news

Press releases & updates

"Zhejiang Huakang Pharmaceutical Co., Ltd."Announcement on Lifting of Restrictions and Listing of Shares for the Second Lifting Period of the Reserved Grant under the 2023 Restricted Share Incentive Plan

"Zhejiang Huakang Pharmaceutical Co., Ltd."Announcement on Abnormal Fluctuations in Stock Trading

"Zhejiang Huakang Pharmaceutical Co., Ltd."Announcement on Shareholding Reduction Plan by Shareholder Holding More Than 5% of the Shares

"Zhejiang Huakang Pharmaceutical Co., Ltd."Announcement on Progress in Providing Guarantee Limit for Wholly-owned Subsidiary

"Zhejiang Huakang Pharmaceutical Co., Ltd."Announcement on Completion of Repurchase and Cancellation of Certain Restricted Shares and Adjustment to the Conversion Price of "Huakang Convertible Bonds"

"Zhejiang Huakang Pharmaceutical Co., Ltd."Announcement on Resolutions of the 4th Meeting of the 7th Board of Directors

"Zhejiang Huakang Pharmaceutical Co., Ltd."Announcement on the Implementation of the Repurchase and Cancellation of Certain Restricted Shares under the Equity Incentive Plan

"Zhejiang Huakang Pharmaceutical Co., Ltd."Announcement on Not Revising Downward the Conversion Price of "Huakang Convertible Bonds"

"Zhejiang Huakang Pharmaceutical Co., Ltd."Semi-annual Performance Forecast for 2026

"Zhejiang Huakang Pharmaceutical Co., Ltd."Announcement on Conversion Result of Convertible Bonds and Share Changes

Announcement on Addition of Implementing Entities for Projects Funded by the Convertible Corporate Bond Issued to Non-specific Objects

Announcement on Adjusting the Total Cash Dividends for the 2025 Annual Profit Distribution

Announcement on Abnormal Fluctuations in Stock Trading

Indicative Announcement on Stopping Conversion of "Huakang Convertible Bonds" when Implementing 2025 Annual Dividend Distribution

Indicative Announcement on Signing of the Supplemental Agreement to the Concerted Action Agreement and Change of Controlling Shareholder, Actual Controller, and Equity Interests

Announcement on Completing Election of Board of Directors at Expiration of Term of Office, and Appointing Senior Management Members, Head of Audit Department and Securities Affairs Representative

Announcement on Convening Performance Briefing for 2025 and Q1 2026

Announcement on Cancellation of Some Proposals for the 2025 Annual General Meeting, Addition of Interim Proposals, and Supplementary Meeting Notice

Announcement on Main Operating Data for Q1 2026

Announcement on Confirmation of Daily Related Party Transactions in 2025 and Estimated Daily Related Party Transactions in 2026

Announcement on Conversion Result of Convertible Bonds and Share Changes

Announcement on Progress in Providing Guarantee Amount for Wholly-owned Subsidiary

Announcement on Cancellation of Special Account for Funds Raised by Issuing Convertible Bonds to Non-specific Objects

Indicative Announcement on Shareholders Holding More Than 5% of Shares Reducing the Convertible Corporate Bonds and Changes in Shareholders' Equity

Announcement on Early Repurchase of Stock Pledge Repurchase Transactions by Some Controlling Shareholders and Their Persons Acting in Concert

Indicative Announcement on Reduction of Convertible Corporate Bonds by the Actual Controller and Its Concerted Parties and Change of Equity

Announcement on Extension of Pledge Repurchase Transactions by Shareholders Holding More Than 5% of Shares

Announcement on the Self-Inspection Report on Stock Trading Activities of Relevant Parties Involved in the Termination of Issuance of Shares and Payment of Cash to Purchase Assets through Related Party Transactions

Announcement on Interest Payment for "Huakang Convertible Bonds" in 2025

Announcement on Holding the Investor Briefing on Terminating Major Asset Restructuring

Announcement on Convening the Q3 2025 Performance Briefing

Announcement on Conducting Commodity Futures, Options, and Foreign Exchange Hedging Business

Announcement on the Closure of the Special Account for Proceeds from the Initial Public Offering

Announcement on Completing Share Transfer of Invested Company

Announcement on Convening the 2025 Semi-annual Performance Briefing

Announcement on Implementation of Semi-annual Dividend Distribution for 2025

Indicative Announcement on Stopping Conversion of "Huakang Convertible Bonds" when Implementing 2025 Interim Dividend Distribution

Announcement on Resignation of Non-independent Director and Election of Employee Representative Director

Announcement on Returning Idle Raised Funds Temporarily Used for Supplementing Current Capital in Advance

Notice on the 2nd Extraordinary General Meeting in 2025

Announcement on Transferring Shares of Invested Company

Announcement on Amendment to Report on Purchasing Assets through Issuance of Shares and Cash Payment and Related Party Transaction (Draft) (Declaration)

Supplementary Announcement on Repurchase and Cancellation of Partial Restricted Stocks to Reduce Registered Capital and Notice to Creditors

Announcement on Receiving Dividends from Wholly-owned Subsidiary

Announcement on Reply to Letter of Supervision and Inquiry from Shanghai Stock Exchange on Information Disclosure of 2024 Annual Report

Announcement on Convening the Q1 2025 Performance Briefing

Announcement on Completing Implementation of Repurchase and Cancellation of Some Restricted Stocks and Adjusting Conversion Price of "Huakang Convertible Bonds"

Announcement on Using Some Idle Raised Funds for Cash Management and Redemption

Announcement on Implementation of Repurchase and Cancellation of Partial Restricted Stocks in Equity Incentive

Announcement on Acceptance of Application for Issuing Shares to Purchase Assets by Shanghai Stock Exchange